In accordance with these genetic trends, we have previously shown that activation of Hras and deletion of Pten (HrasG12V/Pten−/−/TPO-Cre) led to the development of FTC in mice [20]. The gene discussed is TPO; the disease is thyroid cancer, nonmedullary, 2.